Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2021 Filed Feb 18, 2021 22:01 UTC |
Pang PhillipChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 64,000 | $0.00 Strike: $67.38 | $0.00 |
DisclosureSEC source: 0001209191-21-011921 · doc4.xml · derivative · entry 4 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,000 Underlying: Common Stock · 64,000 shares Expires 2031-02-15 F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vest and become exercisable on February 16, 2022, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:01 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001209191-21-011921 · doc4.xml · derivative · entry 3 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,833 Underlying: Common Stock · 10,000 shares Expires 2027-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the 111,110 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:01 UTC |
Pang PhillipChief Medical Officer
|
GrantCommon Stock | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011921 · doc4.xml · nonDerivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,277 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:01 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 10,000 | $0.86 | $8,550.00 |
DisclosureSEC source: 0001209191-21-011921 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:01 UTC |
Rice Steven J.Chief Administrative Officer
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $67.38 | $0.00 |
DisclosureSEC source: 0001209191-21-011917 · doc4.xml · derivative · entry 2 Rice Steven J. · CIK 0001820108 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-02-15 F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vest and become exercisable on February 16, 2022, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:01 UTC |
Rice Steven J.Chief Administrative Officer
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011917 · doc4.xml · nonDerivative · entry 1 Rice Steven J. · CIK 0001820108 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:01 UTC |
SCANGOS GEORGE ADirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 222,000 | $0.00 Strike: $67.38 | $0.00 |
DisclosureSEC source: 0001209191-21-011916 · doc4.xml · derivative · entry 4 SCANGOS GEORGE A · CIK 0001202102 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,000 Underlying: Common Stock · 222,000 shares Expires 2031-02-15 F4 · derivative.exercise_date: 1/4 of the shares subject to the stock option vest and become exercisable on February 16, 2022, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:01 UTC |
SCANGOS GEORGE ADirector · President and CEO
|
GrantCommon Stock | 111,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011916 · doc4.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,609,559 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 16, 2021 Filed Feb 14, 2022 21:08 UTC |
SCANGOS GEORGE ADirector · President and CEO
|
GiftCommon Stock | 900,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009231 · doc5.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,709,559 Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 22:25 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001209191-21-011384 · doc4.xml · derivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,833 Underlying: Common Stock · 10,000 shares Expires 2027-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4 of the 111,110 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 22:25 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 10,000 | $0.86 | $8,550.00 |
DisclosureSEC source: 0001209191-21-011384 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 21:33 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-21-009258 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,255 Underlying: Common Stock · 7,900 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 21:33 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 7,900 | $71.16 | $562,160.84 |
DisclosureSEC source: 0001209191-21-009258 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.0431 to $71.3903 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 21:33 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 7,900 | $1.53 | $12,087.00 |
DisclosureSEC source: 0001209191-21-009258 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 23:00 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,630 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-21-006880 · doc4.xml · derivative · entry 5 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,666 Underlying: Common Stock · 4,630 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 23:00 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,314 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001209191-21-006880 · doc4.xml · derivative · entry 4 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,889 Underlying: Common Stock · 2,314 shares Expires 2027-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 23:00 UTC |
Parrish JayChief Business Officer
|
SaleCommon Stock | 6,944 | $69.91 | $485,424.49 |
DisclosureSEC source: 0001209191-21-006880 · doc4.xml · nonDerivative · entry 3 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,222 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 23:00 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 4,630 | $1.58 | $7,292.25 |
DisclosureSEC source: 0001209191-21-006880 · doc4.xml · nonDerivative · entry 2 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 23:00 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 2,314 | $1.49 | $3,436.29 |
DisclosureSEC source: 0001209191-21-006880 · doc4.xml · nonDerivative · entry 1 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 23:39 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 31,300 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-21-005745 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,155 Underlying: Common Stock · 31,300 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 23:39 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 31,300 | $48.17 | $1,507,805.51 |
DisclosureSEC source: 0001209191-21-005745 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.9959 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 23:39 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 31,300 | $1.53 | $47,889.00 |
DisclosureSEC source: 0001209191-21-005745 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 22:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,530 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-21-004048 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,455 Underlying: Common Stock · 10,530 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 22:00 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 10,530 | $38.00 | $400,140.00 |
DisclosureSEC source: 0001209191-21-004048 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 22:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 10,530 | $1.53 | $16,110.90 |
DisclosureSEC source: 0001209191-21-004048 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2021 Filed Jan 13, 2021 23:38 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,805 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-21-003465 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,985 Underlying: Common Stock · 3,805 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 12, 2021 Filed Jan 13, 2021 23:38 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 3,805 | $29.36 | $111,696.16 |
DisclosureSEC source: 0001209191-21-003465 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.9335 to $30.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 12, 2021 Filed Jan 13, 2021 23:38 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 3,805 | $1.53 | $5,821.65 |
DisclosureSEC source: 0001209191-21-003465 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 21:40 UTC |
Parrish JayChief Business Officer
|
SaleCommon Stock | 6,945 | $26.32 | $182,795.18 |
DisclosureSEC source: 0001209191-21-001158 · doc4.xml · nonDerivative · entry 2 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,222 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 21:40 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 6,945 | $1.49 | $10,313.33 |
DisclosureSEC source: 0001209191-21-001158 · doc4.xml · nonDerivative · entry 1 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Feb 12, 2021 22:00 UTC |
SCANGOS GEORGE ADirector · President and CEO
|
GiftCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-010199 · doc5.xml · nonDerivative · entry 3 SCANGOS GEORGE A · CIK 0001202102 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,498,559 Read SEC document |
| December 24, 2020 Filed Dec 28, 2020 23:39 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,500 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-065247 · doc4.xml · derivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,790 Underlying: Common Stock · 9,500 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 24, 2020 Filed Dec 28, 2020 23:39 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 9,500 | $1.53 | $14,535.00 |
DisclosureSEC source: 0001209191-20-065247 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2020 Filed Dec 23, 2020 23:06 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,805 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-065068 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,290 Underlying: Common Stock · 3,805 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 22, 2020 Filed Dec 23, 2020 23:06 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 3,805 | $31.19 | $118,682.52 |
DisclosureSEC source: 0001209191-20-065068 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.1508 to $31.2380 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 22, 2020 Filed Dec 23, 2020 23:06 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 3,805 | $1.53 | $5,821.65 |
DisclosureSEC source: 0001209191-20-065068 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2020 Filed Dec 11, 2020 21:42 UTC |
Hatfield Jeffrey S.Director
|
GrantStock Option (Right to Buy) · Derivative | 46,500 | $0.00 Strike: $29.43 | $0.00 |
DisclosureSEC source: 0001209191-20-062955 · doc4.xml · derivative · entry 1 Hatfield Jeffrey S. · CIK 0001609879 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,500 Underlying: Common Stock · 46,500 shares Expires 2030-12-08 F1 · derivative.exercise_date: 1/3 of the shares subject to the stock option vest and become exercisable on December 9, 2021, and the remaining shares vest in 24 equal monthly installments thereafter. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 22:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,805 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-062738 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439,095 Underlying: Common Stock · 3,805 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 22:00 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 3,805 | $31.27 | $118,965.61 |
DisclosureSEC source: 0001209191-20-062738 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.2482 to $31.2858 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 22:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 3,805 | $1.53 | $5,821.65 |
DisclosureSEC source: 0001209191-20-062738 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2020 Filed Feb 12, 2021 22:00 UTC |
SCANGOS GEORGE ADirector · President and CEO
|
GiftCommon Stock | 115,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-010199 · doc5.xml · nonDerivative · entry 2 SCANGOS GEORGE A · CIK 0001202102 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 115,000 F1 · ownership.nature: The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees. Read SEC document |
| December 02, 2020 Filed Feb 12, 2021 22:00 UTC |
SCANGOS GEORGE ADirector · President and CEO
|
GiftCommon Stock | 115,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-010199 · doc5.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,598,559 Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 22:48 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,315 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001209191-20-061253 · doc4.xml · derivative · entry 5 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,296 Underlying: Common Stock · 2,315 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 22:48 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,630 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001209191-20-061253 · doc4.xml · derivative · entry 4 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,148 Underlying: Common Stock · 4,630 shares Expires 2027-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 22:48 UTC |
Parrish JayChief Business Officer
|
SaleCommon Stock | 6,945 | $31.53 | $218,967.52 |
DisclosureSEC source: 0001209191-20-061253 · doc4.xml · nonDerivative · entry 3 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,222 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 22:48 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 2,315 | $1.58 | $3,646.13 |
DisclosureSEC source: 0001209191-20-061253 · doc4.xml · nonDerivative · entry 2 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 22:48 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 4,630 | $1.49 | $6,875.55 |
DisclosureSEC source: 0001209191-20-061253 · doc4.xml · nonDerivative · entry 1 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2020 Filed Jan 5, 2021 21:40 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,945 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001209191-21-001158 · doc4.xml · derivative · entry 3 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,203 Underlying: Common Stock · 6,945 shares Expires 2027-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 27, 2020 Filed Dec 2, 2020 00:03 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001209191-20-060970 · doc4.xml · derivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,833 Underlying: Common Stock · 7,500 shares Expires 2027-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4 of the 111,110 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 27, 2020 Filed Dec 2, 2020 00:03 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 7,500 | $0.86 | $6,412.50 |
DisclosureSEC source: 0001209191-20-060970 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.